Vertex Pharmaceuticals Incorporated (FRA:VX1)
330.45
-2.25 (-0.68%)
At close: Sep 30, 2025
Vertex Pharmaceuticals Market Cap
Vertex Pharmaceuticals has a market cap or net worth of €86.39 billion as of September 30, 2025. Its market cap has decreased by -22.83% in one year.
Market Cap
86.39B
Enterprise Value
77.44B
Revenue
9.72B
Ranking
n/a
PE Ratio
27.89
Stock Price
€330.45
Market Cap Chart
Since July 24, 1991, Vertex Pharmaceuticals's market cap has increased from 73.88M to 86.39B, an increase of 116,832.91%. That is a compound annual growth rate of 22.94%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Sep 29, 2025 | 86.39B | -13.75% |
Dec 31, 2024 | 100.17B | 5.60% |
Dec 29, 2023 | 94.86B | 36.76% |
Dec 30, 2022 | 69.36B | 41.28% |
Dec 31, 2021 | 49.09B | -2.28% |
Dec 31, 2020 | 50.24B | 0.14% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
SAP SE | 262.21B |
Siemens Aktiengesellschaft | 177.42B |
Deutsche Telekom AG | 136.77B |
Allianz SE | 136.28B |
Rheinmetall AG | 89.95B |
Siemens Energy AG | 84.11B |
Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München | 69.76B |
Deutsche Bank Aktiengesellschaft | 58.48B |